In this segment, Jeffrey D. Dunn, PharmD, MBA, and Yehuda Handelsman, MD, FACP, FACE, FNLA, comment that traditional diabetes management techniques, such as distributing newsletters and brochures to patients, have not improved overall adherence rates to therapy among patients with type 2 diabetes mellitus.
Dr Handelsman adds that most patients discard pamphlets without ever reviewing them, and suggests that other adherence-promoting measures may be more effective.
Peter Salgo, MD; Maria Lopes, MD, MS; and Drs Dunn and Handelsman emphasize the importance of social support for patients with diabetes. Dr Lopes explains that social support programs need to be tailored specifically for each individual patient, because different patients have different needs.
Together, the panelists discuss the importance of coordination of care among all stakeholders involved in the patient’s care, including physicians, nurses, dietitians, pharmacists, and health plans. Dr Lopes explains that providers need to work as a team to educate, train, motivate, and assess the patient as an individual and help them throughout the entire treatment process.
Kari Uusinarkaus, MD, FAAFP, FNLA, describes a program that allows patients with diabetes to go shopping with a dietitian in a grocery store. However, Dr Salgo asks about the costs of such a program.
Drs Dunn and Handelsman argue that although programs to improve patient adherence are costly, they are important. Dr Dunn adds that it is more cost-effective to prevent diabetes than to treat it.
Managed Care Reflections: A Q&A With A. Mark Fendrick, MD, and Michael E. Chernew, PhD
December 2nd 2025To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The December issue features a conversation with AJMC Co–Editors in Chief A. Mark Fendrick, MD, director of the Center for Value-Based Insurance Design and a professor at the University of Michigan in Ann Arbor; and Michael E. Chernew, PhD, the Leonard D. Schaeffer Professor of Health Care Policy and the director of the Healthcare Markets and Regulation Lab at Harvard Medical School in Boston, Massachusetts.
Read More